Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,149,024 papers from all fields of science
Search
Sign In
Create Free Account
VEGFR2-targeted Contrast Agent BR55
Known as:
BR55
A lipopeptide-based, vascular endothelial growth factor receptor 2 (VEGRF2) -targeted contrast agent with the property of molecular imaging of…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Liver dysplasia: US molecular imaging with targeted contrast agent enables early assessment.
C. Grouls
,
Max Hatting
,
+7 authors
M. Palmowski
Radiology
2013
Corpus ID: 207735246
PURPOSE To investigate the ability of vascular endothelial growth factor receptor type 2 (VEGFR2)-targeted ultrasonographic (US…
Expand
Highly Cited
2011
Highly Cited
2011
Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38)
J. Bzyl
,
W. Lederle
,
+8 authors
M. Palmowski
European Radiology
2011
Corpus ID: 25531545
ObjectivesTo characterise clinically translatable long-circulating (BR38) and VEGFR2-targeted (BR55) microbubbles (MB) and to…
Expand
2001
2001
Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression
D. Flieger
,
A. Hoff
,
Tilman Sauerbruch
,
I. G. Schmidt-Wolf
Clinical and Experimental Immunology
2001
Corpus ID: 6258482
MoAbs against tumour‐associated antigens (TAA) may be useful for the treatment of colorectal cancer. Since an increased…
Expand
Highly Cited
2000
Highly Cited
2000
A Molecular Basis for Functional Peptide Mimicry of a Carbohydrate Antigen*
P. Luo
,
G. Canziani
,
G. Cunto-Amesty
,
T. Kieber‐Emmons
Journal of Biological Chemistry
2000
Corpus ID: 26013508
Peptides may substitute for carbohydrate antigens in carbohydrate-specific immunological reactions. Using the recognition…
Expand
1999
1999
Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines.
D. Flieger
,
U. Spengler
,
+5 authors
I. Schmidt-Wolf
Hybridoma
1999
Corpus ID: 22743876
Monoclonal antibodies (MAb) specific for tumor-associated antigens (TAA) can induce an immunological cellular attack of tumor…
Expand
Highly Cited
1998
Highly Cited
1998
Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens.
Ping Luo
,
M. Agadjanyan
,
Jianping Qiu
,
M. Westerink
,
Zenon Steplewski
,
Thomas Kieber-Emmons
Molecular Immunology
1998
Corpus ID: 20456906
1996
1996
Molecular recognition of the Lewis Y antigen by monoclonal antibodies.
Magdalena Blaszczyk-Thurin
,
Ramacbandran Murali
,
Julie Westerink
,
Zenon Steplewski
,
Man Sung Co
,
Thomas Kieber-Emmons
Protein Engineering
1996
Corpus ID: 14283680
The murine monoclonal antibody BR55-2 is directed against the tumor-associated antigen Lewis Y oligosaccharide. The Lewis Y core…
Expand
1991
1991
Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide.
Zenon Steplewski
,
Lubeck
,
D. Scholz
,
H. Loibner
,
J. McDonaldSmith
,
H. Koprowski
In Vivo
1991
Corpus ID: 7755567
IgG3 murine MAb BR55-2 is directed against adenocarcinoma associated Y oligosaccharide. Isotype IgG1, IgG2b and IgG2a switch…
Expand
1990
1990
Oligosaccharide Y specific monoclonal antibody and its isotype switch variants.
Z. Steplewski
,
M. Blaszczyk‐Thurin
,
M. Lubeck
,
H. Loibner
,
D. Scholz
,
H. Koprowski
Hybridoma
1990
Corpus ID: 46591315
Isotype switch variants of the IgG3 secreting hybridoma BR55-2 were developed with gamma 1, gamma 2b and gamma 2a heavy chains…
Expand
1989
1989
The tumor-associated antigens BR55-2, GA73-3 and GICA 19-9 in normal and corresponding neoplastic human tissues, especially gastrointestinal tissues.
J. Shetye
,
Birger Christensson
,
Carlos A. Rubio
,
M. Rodensjö
,
Peter Biberfeld
,
Håkan Mellstedt
Anticancer Research
1989
Corpus ID: 30659847
Immunohistochemical analysis with a monoclonal antibody, anti-BR55-2, was carried out on 163 tumors with their adjacent normal…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE